Abiopharma

New Form 8-K - Dyne Therapeutics, Inc. Filed: 2025-07-01 AccNo: 0001193125-25-154057 Size: 475 KB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits